Insider Trading March 24, 2026

Janus Living Director Purchases $110,000 in Stock as Company Strengthens Balance Sheet

Charles J. Herman Jr. buys Class A-1 shares amid recent financing moves and an IPO that raised $840 million

By Maya Rios JAN
Janus Living Director Purchases $110,000 in Stock as Company Strengthens Balance Sheet
JAN

Janus Living director Charles J. Herman Jr. purchased 5,500 shares of Class A-1 Common Stock at $20 per share on March 23, 2026, for $110,000. The company's shares trade at $23.75, near a 52-week high of $24.36. The filing also discloses additional no-cost issuances, and the company recently closed a $600 million credit facility and completed an IPO that raised $840 million.

Key Points

  • Director Charles J. Herman Jr. purchased 5,500 shares of Class A-1 Common Stock at $20 per share on March 23, 2026, for $110,000.
  • Janus Living shares trade at $23.75, nearly 19% above the purchase price and close to a 52-week high of $24.36; the company is reported at a $6.1 billion market capitalization.
  • The company closed a $600 million credit facility (a $500 million unsecured revolving facility and a $100 million unsecured delayed-draw term loan) with maturities in March 2030 and March 2031, and its IPO priced at $20 per share, raising $840 million.

Transaction details

Director Charles J. Herman Jr. of Janus Living, Inc. bought 5,500 shares of the company’s Class A-1 Common Stock at $20.00 per share, a purchase that amounted to $110,000 in total. The purchase is recorded in a Form 4 filed with the Securities and Exchange Commission and is dated March 23, 2026.

The filing also shows Herman acquired two additional tranches of Class A-1 stock at no cost: 2,500 shares and 5,000 shares. Company shares are currently quoted at $23.75, a price level that represents nearly a 19% increase from the $20 purchase price and sits close to the 52-week high of $24.36.


Company valuation and trading context

Data cited in the filing places the company’s market capitalization at $6.1 billion and records the share price near its 52-week high. The transaction and the share-price context are presented without additional commentary in the filing.


Recent financing and IPO activity

Janus Living has completed a series of material financing exercises in the most recent period. The company closed a $600 million credit facility that consists of a $500 million unsecured revolving credit line and a $100 million unsecured delayed-draw term loan facility. The revolving credit agreement matures in March 2030, while the delayed-draw term loan reaches maturity in March 2031. The company characterized those facilities as providing extended financial flexibility.

Separately, Janus Living priced its initial public offering at $20 per share, the top of the marketed range, raising $840 million in proceeds. That total exceeds an earlier target of $740 million and reflects an increase in the base size of the offering by $100 million.


Context and limitations

The filings and company disclosures document the insider purchase, the no-cost share issuances to Herman, the current trading price and the recent credit and IPO transactions. The public documents cited do not provide additional detail in this release about the specific use of proceeds from the credit facilities or the IPO beyond the amounts raised and the stated maturities for the debt facilities.

Bottom line

Charles J. Herman Jr.’s purchase of 5,500 Class A-1 shares at $20 per share was executed on March 23, 2026, and valued at $110,000. The company has concurrently completed a $600 million credit facility and an IPO that generated $840 million, milestones that are recorded in the company’s public disclosures.

Risks

  • Share price uncertainty: the stock is trading near its 52-week high of $24.36, and future price direction is not disclosed in the filings.
  • Limited disclosure on proceeds usage: public documents cited do not specify how the company intends to use proceeds from the credit facilities or the IPO beyond the amounts raised and maturities.
  • Incomplete details on no-cost issuances: the Form 4 records no-cost acquisitions of 2,500 and 5,000 shares by Herman but does not provide further explanation in the filing excerpt presented.

More from Insider Trading

Hinge Health CFO James Budge Sells $465K in Class A Shares Mar 24, 2026 Hinge Health President Disposes of $633,927 in Stock via 10b5-1 Plan Mar 24, 2026 Silver Lake Sells $49.3M of Dell Class C Stock as Conversions, Corporate Upgrades Also Reported Mar 24, 2026 Bristow Director Disposes of 1,000 VTOL Shares in $45,000 Transaction Mar 24, 2026 Serina Therapeutics CSO Sells Shares, Exercises Options as Company Advances Parkinson’s Program Mar 24, 2026